High complete remission rate and durable remissions achieved with rational use of autologous stem-cell transplantation, thalidomide maintenance, and non-myeloablative allogeneic transplantation in patients with multiple myeloma.
Atıf İçin Kopyala
Oyan B., Koc Y., Ozdemir E., Kars A., Turker A., Tekuzman G., ...Daha Fazla
Clinical transplantation, cilt.23, ss.839-47, 2009 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
23
-
Basım Tarihi:
2009
-
Doi Numarası:
10.1111/j.1399-0012.2008.00950.x
-
Dergi Adı:
Clinical transplantation
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.839-47
-
Anahtar Kelimeler:
autologous, multiple myeloma, non-myeloablative, thalidomide, transplantation, HIGH-DOSE THERAPY, DEXAMETHASONE, CHEMOTHERAPY, SURVIVAL, MELPHALAN
-
Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli:
Hayır